Tilray Inc (TLRY) - Cash Flow Conversion Efficiency

Latest as of November 2025: -0.006x

Based on the latest financial reports, Tilray Inc (TLRY) has a cash flow conversion efficiency ratio of -0.006x as of November 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-11.93 Million) by net assets ($2.16 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Tilray Inc - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Tilray Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Tilray Inc (TLRY) financial obligations for a breakdown of total debt and financial obligations.

Tilray Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tilray Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Foshan Nationstar Optoelectronics Co Ltd
SHE:002449
0.024x
Brookfield Real Assets Income
NYSE:RA
0.040x
Shenzhen Etmade Automatic Equipment
SHE:300812
0.067x
Ningbo Sinyuan ZM Technology Co. Ltd. A
SHE:301398
N/A
Dodla Dairy Limited
NSE:DODLA
0.024x
Seneca Foods Corp A
NASDAQ:SENEA
0.044x
Yabao Pharmaceutical Group Co Ltd
SHG:600351
0.047x
Vgi Partners Global Investments Ltd
AU:VG1
0.143x

Annual Cash Flow Conversion Efficiency for Tilray Inc (2012–2025)

The table below shows the annual cash flow conversion efficiency of Tilray Inc from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see Tilray Inc (TLRY) market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-05-31 $2.04 Billion $-129.81 Million -0.064x -607.55%
2024-05-31 $4.69 Billion $-42.11 Million -0.009x -609.22%
2023-05-31 $4.49 Billion $7.91 Million 0.002x +105.57%
2022-05-31 $5.60 Billion $-177.26 Million -0.032x -161.85%
2021-05-31 $4.47 Billion $-53.99 Million -0.012x +98.66%
2020-05-31 $380.01 Million $-343.77 Million -0.905x -286.62%
2019-05-31 $269.10 Million $-62.97 Million -0.234x -118.91%
2018-05-31 $-6.17 Million $-7.63 Million 1.237x +194.26%
2017-05-31 $3.42 Million $-4.48 Million -1.313x -4550.71%
2016-05-31 $26.85 Million $-757.62K -0.028x +93.08%
2015-05-31 $10.74 Million $-4.38 Million -0.408x -169.35%
2014-05-31 $271.84K $-41.16K -0.151x 0.00%
2013-05-31 $271.84K $-41.16K -0.151x -17.18%
2012-05-31 $333.15K $-43.05K -0.129x --

About Tilray Inc

NASDAQ:TLRY USA Drug Manufacturers - Specialty & Generic
Market Cap
$717.68 Million
Market Cap Rank
#10717 Global
#2653 in USA
Share Price
$6.16
Change (1 day)
-1.28%
52-Week Range
$0.36 - $13.94
All Time High
$214.06
About

Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; resells and… Read more